Back to Search Start Over

18F-FDG PET/CT for Monitoring of Disease Progression in Metastatic Perivascular Epithelioid Cell Tumor.

Authors :
Holzgreve A
Fabritius MP
Knösel T
Renz BW
Lindner LH
Di Gioia D
Bartenstein P
Rübenthaler J
Tiling R
Source :
Clinical nuclear medicine [Clin Nucl Med] 2021 Feb 01; Vol. 46 (2), pp. 156-158.
Publication Year :
2021

Abstract

Abstract: A 38-year-old woman presented for 18F-FDG PET/CT after multiple intra-abdominal surgical resections of a rare recurrent perivascular epithelioid cell tumor of the gastrointestinal tract. A solitary pelvic metastasis was detected, but surprisingly exhibited neither increased glucose consumption nor contrast enhancement on CT. Follow-up 18F-FDG PET/CT staging in the further disease course revealed multiple abdominal metastases, now, however, with markedly increased 18F-FDG uptake and intraoperatively correlating widespread peritoneal sarcomatosis. This case gives preliminary insight into monitoring of disease progression in metastatic perivascular epithelioid cell tumor, although the underlying pathophysiological bases for varying 18F-FDG uptake in PET/CT are not yet fully understood.<br />Competing Interests: Conflicts of interest and sources of funding: none declared.<br /> (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1536-0229
Volume :
46
Issue :
2
Database :
MEDLINE
Journal :
Clinical nuclear medicine
Publication Type :
Academic Journal
Accession number :
33315683
Full Text :
https://doi.org/10.1097/RLU.0000000000003453